MENU
+Compare
CYDY
Stock ticker: OTC
AS OF
Jul 18 closing price
Price
$0.32
Change
-$0.00 (-0.00%)
Capitalization
388.96M

CYDY CytoDyn Inc. Forecast, Technical & Fundamental Analysis

CytoDyn Inc is a USA-based clinical-stage biotechnology company that focuses on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection... Show more

CYDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CYDY with price predictions
Jul 18, 2025

CYDY sees its Stochastic Oscillator ascends from oversold territory

On July 07, 2025, the Stochastic Oscillator for CYDY moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 74 instances where the indicator left the oversold zone. In of the 74 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CYDY's RSI Oscillator exited the oversold zone, of 46 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 10, 2025. You may want to consider a long position or call options on CYDY as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CYDY just turned positive on July 09, 2025. Looking at past instances where CYDY's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CYDY advanced for three days, in of 229 cases, the price rose further within the following month. The odds of a continued upward trend are .

CYDY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

CYDY moved below its 50-day moving average on June 25, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CYDY crossed bearishly below the 50-day moving average on June 27, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CYDY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CYDY entered a downward trend on July 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.143). P/E Ratio (0.000) is within average values for comparable stocks, (58.647). CYDY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (270.975).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CYDY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYDY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CYDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1111 Main Street
Phone
+1 360 980-8524
Employees
12
Web
https://www.cytodyn.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NRECX13.900.04
+0.29%
Neuberger Berman Real Estate C
RMBNX43.180.09
+0.21%
RMB Mendon Financial Services C
TFCGX19.67-0.03
-0.15%
Taylor Frigon Core Growth
BBVSX14.68-0.03
-0.20%
Bridge Builder Small/Mid Cap Value
TSRMX16.35-0.08
-0.49%
Touchstone Sands Cptl Emerg Mkts Gr R6

CYDY and Stocks

Correlation & Price change

A.I.dvisor tells us that CYDY and TNXP have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYDY and TNXP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYDY
1D Price
Change %
CYDY100%
-0.13%
TNXP - CYDY
22%
Poorly correlated
-0.59%
AGNPF - CYDY
21%
Poorly correlated
-1.10%
CLNN - CYDY
20%
Poorly correlated
-2.05%
GNNSF - CYDY
16%
Poorly correlated
+26.95%
GNMSF - CYDY
14%
Poorly correlated
-1.19%
More